Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study49

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study25

Views

Views
October 20240
November 20241
December 20246
January 20251
February 20251
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United Kingdom4
United States2
United Arab Emirates2
Germany1
 

Top cities views

Views
London3